MSK researcher: AI-designed proteins to push tumor-control limits in preclinical models
anshulkundaje · x · 2026-09-10
Caleb Lareau of Memorial Sloan Kettering Cancer Center says his team will keep pushing what AI-designed proteins can do to control tumors in preclinical models over the next few years, aiming to meet patient needs soon.
Related event: MSK's AI-Designed Anti-Cancer Proteins Fully Clear Tumors in Mice(3 posts)→
More from Research
- JockeyBench uses Japanese horse racing to test LLM agents — all betting strategies lose money — Zhongwei Xie · 2026-10-27
- Stanford's PaperFormalizer turns research papers into Lean-verified versions with author in the loop — StanfordUniversity · 2026-10-27
- Cohere's Invent-A-Dataset paper: zero-seed synthetic data beats frontier APIs on quality and diversity — idanbeck · 2026-10-27
- Hugging Face TRL makes score centering + masked importance sampling default in async GRPO — _lewtun · 2026-10-27
- EMNLP 2026: sub-billion-parameter LMs show superhuman entity tracking, human-like fleeting memory — GretaTuckute · 2026-10-27
- 10-year study documents first 'unnatural gradient' phonotactic restriction in Tarma Quechua — begusgasper · 2026-10-27